BYTAZRA

Pharmaceutical preparations for the post-exposure preventive treatment or treatment of rabies; Pharmaceutical preparations and substances for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral infections; Chemical preparations for pharmaceutical or medical purposes, namely, for the post-exposure preventive treatment or treatment of rabies; Veterinary preparations for dogs or cats for the post-exposure preventive treatment or treatment of rabies; Veterinary pharmaceutical preparations for the treatment of rabies; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Biological preparations for the post-exposure preventive treatment or treatment of rabies; Syringes sold filled with Zamerovimab and Mazorelvimab; Vaccines; Blood for medical purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Chemical reagents for medical or veterinary purposes; Reagent paper for medical purposes; Reagent paper for veterinary purposes